FIGURE 1.

Percentage endorsement of breast cancer prevention recommendations for clinical scenarios.

Mammography: all scenarios significantly different from scenario D. Scenarios E and F also differed significantly (all P < .001). Lifestyle: scenario A significantly different from scenarios C and D; scenario B significantly different from scenarios C, E, and F; scenario C significantly different from scenarios E and F; scenario D significantly different from scenarios A, E, and F (all P < .001).

Discuss genetic evaluation: all scenarios significantly different from each other except scenarios A and F, and B and C (all P < .001).

Discuss tamoxifen: all scenarios significantly different from each other except scenarios C and D, and E and F (all P < .001).

Discuss surgery: all scenarios significantly different from each other except scenarios A and E, A and F, C and D, and E and F (all P < .001).

Refer to a specialist: all scenarios significantly different from each other except scenarios A and B, A and F, and B and F (all P < .001).